Update on Hande's new facility -2019.8.5

Author:admin    Time:2019-08-07 16:27    Click:


1.     
Natural Paclitaxel Manufacture Line:
Accelerated stability test for third month is over (three batches: 800~1000 g/batch). Third-party inspection of metal elements is finished. Hande method validation is in progress. The fourth batch, commercial batch (800~1000 g/batch), is produced on 5-Aug, which is testing and packing that estimated testing is to be ended on 19-Aug.


2.      Initial Processing Line:
Regular producing and sales of 10-DAB III. Process optimization validation keep going to improve capacity for meeting the needs of natural paclitaxel.

2019 CPHI CHINA-E5F42

=CPHI WW 2019 INVITATION

关注汉德

  • Official WeChat

链接

CopyRight 2010 Yunnan Hande Bio-Tech Co., Ltd. © All rights reserved
邮箱:sales@handebio.com
电话: +86-871-65313300 传真: +86-871-65329081
地址 : 云南省昆明市安宁太平新城创智2.5产业园